---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-010674"
form_type: "8-K"
ticker: "NXPL"
cik: "0001058307"
company_name: "NextPlat Corp"
filed_at: "2026-03-31T23:59:59+00:00"
generated_at: "2026-05-15T08:05:28.479523+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# NextPlat reports FY2025 revenue $54.3M, net loss $0.44/share; cost cuts of $2M+

## Summary
- Revenue $54.3M, down 18% YoY; healthcare revenue fell to $39.7M, e-commerce rose to $14.6M.
- Net loss attributable to common stockholders $11.7M ($0.44 per diluted share) vs $13.4M ($0.65) prior year.
- Operating expenses cut 50% to $19.9M; headcount reduced >25%, $2M+ annualized cost savings.
- Cash $13.7M, no meaningful debt, working capital $15M; gross margin fell to 20% from 26%.
- New leadership: Rodney Barreto Chairman, David Phipps CEO, Amanda Ferrio CFO, Birute Norkute VP Healthcare.

## SEC filing metadata
- accession: 0001437749-26-010674
- form_type: 8-K
- ticker: NXPL
- cik: 0001058307
- company_name: NextPlat Corp
- filed_at: 2026-03-31T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/0001437749-26-010674-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/nxpl20251122_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-010674
- JSON: https://secwatch.observer/filing/0001437749-26-010674.json
- Plain text: https://secwatch.observer/filing/0001437749-26-010674.txt

## Key facts
- Earnings Releases
  NextPlat Corp reported year ended December 31, 2025 results: revenue approximately $54.3 million, net income Net loss attributable to common stockholders for the year ended December 31, 2025, was approximately $11.7 million, or (, EPS ($0.44) per diluted share.
  - Period: year ended December 31, 2025
  - Revenue: approximately $54.3 million
  - Net income: Net loss attributable to common stockholders for the year ended December 31, 2025, was approximately $11.7 million, or (
  - EPS: ($0.44) per diluted share
  - Result: reported results
  source text: our shareholders for quite some time.” Fourth Quarter and Full Year 2025 Financial Highlights ● Consolidated revenue for the full year ended December 31, 2025, was approximately $54.3 million, compared to approximately $66.1 million for the prior year, an overall decrease of 18%. ○ Full year 2025 Healthcare Operations revenue decreased approximately $12.6 million to
  evidence_url: https://www.sec.gov/Archives/edgar/data/1058307/000143774926010674/0001437749-26-010674-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.